Navigation Links
Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Canaccord Adams Global Growth Conference in Boston on August 11, 2009
Date:8/4/2009

SAN DIEGO, Aug. 4 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's President and CEO Theodore Schroeder will present the company's corporate overview on Tuesday, August 11, 2009 at 4:30pm Eastern Time (1:30pm Pacific Time) during the Canaccord Adams Global Growth Conference at the Intercontinental Hotel in Boston.

The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com in the Investor Relations section. A replay of the webcast will be available approximately three hours following the live webcast and will be archived for 90 days.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company is currently developing Acetavance(TM) (intravenous acetaminophen), its investigational product candidate for the treatment of acute pain and fever. For more information about Cadence's pipeline, visit www.cadencepharm.com.

Cadence(TM) and Acetavance(TM) are trademarks of Cadence Pharmaceuticals, Inc.

    William R. LaRue
    SVP, CFO
    Cadence Pharmaceuticals, Inc.
    858-436-1400


'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Cadence Pharmaceuticals Chief Medical Officer James Breitmeyer to Present at JMP Securities Healthcare Focus Conference
2. Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
3. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results and Provides Corporate and Clinical Program Overview
4. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter Financial Results and Provide a Clinical Program Update on May 6, 2008
5. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on June 11, 2008 in New York
6. Cadence Pharmaceuticals Announces Positive Topline Results of Phase III Clinical Trial of Acetavance in Laparoscopic Surgery
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the BIO CEO and Investor Conference in New York City
8. Cadence Pharmaceuticals to Raise $86.6 Million in a Private Placement of Common Stock
9. Cadence Pharmaceuticals Completes $86.6 Million Private Placement of Common Stock
10. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Cowen & Companys 29th Annual Health Care Conference in Boston on March 16, 2009
11. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2009 Financial Results on May 7, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Health Workforce Recommendations are Implemented ,, ... must ensure that health reform includes a ... to ensure implementation of an integrated, coordinated ... Steven A Wartman, president and CEO of ... "With each step in the legislative ...
(Date:12/14/2009)... lacerations, accidental ingestion of ornament fragments by children ... A new study from Children,s Hospital Boston,s Division ... particularly glass ornaments, are one more safety hazard ... of records from Children,s Emergency Department revealed an ... than half of these injuries involve a child ...
(Date:12/14/2009)... Following is a statement of Matthew L. Myers, ... http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ) ,, The 2009 Monitoring the Future ... Drug Abuse shows that the nation continues to ... declines have slowed significantly compared to the dramatic ... troubling news, the survey also finds that smokeless ...
(Date:12/14/2009)... to approve naming the women,s hospital -- located within ... -- after Ted and Jane Von Voigtlander ,, ... of Michigan Health System has received a $15 million ... the largest gift ever made to the Health System ... a new women,s hospital. ,, The gift is being ...
(Date:12/14/2009)... Athens, Ga. A new study published by researchers ... Center in Tampa, Fla., has found that cancer patients ... patients with cancer alone, even after controlling for factors ... But the study, published in the early online edition ... also argues that a diagnosis of dementia shouldn,t discourage ...
Breaking Medicine News(10 mins):Health News:Health Reform Needs Enforceable National Workforce Strategy 2Health News:Parents: Be Mindful of Hazardous Holiday Ornaments 2Health News:Parents: Be Mindful of Hazardous Holiday Ornaments 3Health News:New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts 2Health News:New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts 3Health News:New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts 4Health News:New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts 5Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 2Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 3Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 4Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 5Health News:Study finds significantly worse outcomes in cancer patients with cognitive impairment 2Health News:Study finds significantly worse outcomes in cancer patients with cognitive impairment 3
... Label Identifies ,Farm to Fork, Care and Prevention, ... raised and handled,with rigorous and higher new safety ... by a cooperative of leading farmers and,ranchers behind ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080401/AQTU070LOGO ), Citing growing consumer ...
... April 1, 2008 Natural,Nutrition, Inc. (OTC Bulletin ... operating,subsidiary, InterACTIVE Nutrition, Inc. (INII) achieved record unaudited,sales ... in EBITDA for the,year ended December 31, 2007., ... "We are pleased to,report record results for our ...
... /Xinhua-PRNewswire-FirstCall/ -- China,Shenghuo Pharmaceutical Holdings, Inc. (Amex: ... engaged in the research, development, manufacture,and marketing of ... Republic of China ("PRC"), announced its financial,results for ... Full Year 2007 Highlights -- Net ...
... largest survey ever of American physicians opinions on health-care ... government legislation to establish national health insurance while only ... the IU researchers in 2002 found 49 percent of ... it. , The 2007 survey results demonstrate ...
... Calif., March 31, 2008 Grubb & Ellis,Healthcare ... Station,Medical Office Building in Houston., Located at ... renovated,three-story multi-tenant medical office building. Built on approximately,2.6 ... 54,000 square feet of gross leaseable area and ...
... Urging EPA to Fix Rule Flaws, WASHINGTON, March ... Center for Healthy Housing praise the new EPA regulation ... workers and occupants from,exposure to unhealthy levels of lead ... buildings built before,1978. At the same time, they say ...
Other Medicine News:Health News:'VeriPrime Certified Safeguards' Food Safety Label Unveiled 2Health News:'VeriPrime Certified Safeguards' Food Safety Label Unveiled 3Health News:Natural Nutrition Subsidiary Reports Record Year-End Revenue and EBITDA 2Health News:China Shenghuo Reports Full Year 2007 Financial Results 2Health News:China Shenghuo Reports Full Year 2007 Financial Results 3Health News:China Shenghuo Reports Full Year 2007 Financial Results 4Health News:China Shenghuo Reports Full Year 2007 Financial Results 5Health News:China Shenghuo Reports Full Year 2007 Financial Results 6Health News:China Shenghuo Reports Full Year 2007 Financial Results 7Health News:China Shenghuo Reports Full Year 2007 Financial Results 8Health News:China Shenghuo Reports Full Year 2007 Financial Results 9Health News:China Shenghuo Reports Full Year 2007 Financial Results 10Health News:China Shenghuo Reports Full Year 2007 Financial Results 11Health News:China Shenghuo Reports Full Year 2007 Financial Results 12Health News:China Shenghuo Reports Full Year 2007 Financial Results 13Health News:Indiana University study finds majority of US physicians favor national health insurance 2Health News:Grubb & Ellis Healthcare REIT Acquires Cypress Station Medical Office Building in Houston 2Health News:Grubb & Ellis Healthcare REIT Acquires Cypress Station Medical Office Building in Houston 3Health News:Federal Regulation Will Require Renovators to Work Safely with Lead-Paint 2Health News:Federal Regulation Will Require Renovators to Work Safely with Lead-Paint 3
(Date:12/14/2009)... Fla., Dec. 14 When staff from ... to apply the difficult to adjust and uncomfortable ... enlisted Professional Products, Inc. (PPI) to develop a ... in orthopaedic solutions for nearly five decades, responded ... cubitaltunnelsplint.com ), which it announced today. Simple ...
(Date:12/14/2009)... -- Mylan Inc. (Nasdaq: MYL ) today ... the NASDAQ-100 Index Dec. 21. Mylan,s common shares ... ,, Mylan Chairman and CEO Robert J. Coury ... most widely followed index of leading companies. This ... and reflects the rapid growth and strong potential ...
(Date:12/14/2009)... Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced ... the addition of Lt. Gen. Ronald R. Blanck, DO, ... Blanck & Associates, a federal health services consulting firm ... company board now has nine members. ,, Dr. Blanck ... officer and battalion surgeon in Vietnam. He retired 32 ...
Breaking Medicine Technology:New Cubital Tunnel Splint Specially Designed for Comfort and Less Cumbersome Fit 2Mylan Added to NASDAQ-100 Index 2Oxygen Biotherapeutics, Inc. Expands Board of Directors 2CWRU receives 245 million from Ohio Third Frontier Commission 9009 1CWRU receives 245 million from Ohio Third Frontier Commission 9009 2CWRU receives 245 million from Ohio Third Frontier Commission 9009 3The Leapfrog Group Announces New Board Chair 50087 1The Leapfrog Group Announces New Board Chair 50087 2The Leapfrog Group Announces New Board Chair 50087 3Hundreds of Genes Could Be Linked to ADHD 50082 1Hundreds of Genes Could Be Linked to ADHD 50082 2
... Boston,Scientific Corporation (NYSE: BSX ) today announced ... its TAXUS ARRIVE 1 and 2 registries, which,are ... Express2(TM),Paclitaxel-Eluting Coronary Stent System in real-world practice. The,two-year ... reduced clinical,restenosis in patients with diabetes as effectively ...
... Show Prophylaxis Treatment with Kogenate FS Reduces the,Risk ... with No Pre-Existing,Joint Damage, BERKELEY, Calif., Oct. ... U.S. Food and Drug Administration (FDA) has,approved routine ... the frequency of bleeding episodes and the risk ...
Other Medicine Technology:TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 3FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 5
... Our greatest generation yet, the all-new ... designed to meet the growing demands of ... as qcProGuard, ProGrip design, backlighting, and strip ... , To test, simply insert the test ...
... For practices performing routine Holter,monitoring, ... QuickStep Wizard provides a,practical, no-nonsense ... managed health care,environment. This highly ... in a variety,of configurations at ...
... Vision5L Digital Holter ... or 7-lead, 3-channel,Holter ... signal preview,screen. Fast ... a compact,flash card ...
... The Elite II features a ... University of Glasgow,(UG) algorithm. Unlike ... to age, the UG,algorithm bases ... criteria: gender, age, race, medication,and ...
Medicine Products: